Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
2.115
+0.015 (0.71%)
Apr 28, 2025, 9:39 AM EDT - Market open
KYTX's stock price has decreased by -88.14% in the past year and price targets may not have had time to catch up.
Kyverna Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
$18.80
Upside
+788.89%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $6 → $4 | Hold | Maintains | $6 → $4 | +89.13% | Apr 3, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $40 → $20 | Buy | Maintains | $40 → $20 | +845.63% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +183.69% | Nov 20, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $44 → $24 | Buy | Maintains | $44 → $24 | +1,034.75% | Nov 15, 2024 |
| UBS | UBS | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +514.66% | Oct 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $7 | Hold | Reiterates | $7 | +230.97% | Sep 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +230.97% | Aug 15, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $39 → $33 | Buy | Maintains | $39 → $33 | +1,460.28% | Jul 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $8 | Hold | Reiterates | $8 | +278.25% | Jul 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Initiates $8 | Hold | Initiates | $8 | +278.25% | Jul 3, 2024 |
| JP Morgan | JP Morgan | Buy Initiates $39 | Buy | Initiates | $39 | +1,743.97% | Mar 4, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $40 | Buy | Initiates | $40 | +1,791.25% | Mar 4, 2024 |